{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:16:46Z","timestamp":1789010206988,"version":"build-2803163510"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Alopecia areata (AA) is an autoimmune disease mediated by NKG2D-expressing cytotoxic T lymphocytes destroying hair follicles in the skin. It is one of the most common autoimmune diseases, but there is no effective treatment modality approved by the FDA. Regulatory T cells (Tregs) are crucial for suppressing autoreactive T cells, and in the skin, they promote hair growth by inducing anagen. Based on this, we tested the therapeutic potential of expanded Tregs in AA using the C3H\/HeJ mouse model. In mice with AA, NKG2D-expressing CD8 T cells widely infiltrate both haired and hairless skin areas, which have tissue-resident memory T-cell phenotypes. Tregs in the skin express CD25, CTLA-4, GATA-3, and Jagged1 and efficiently proliferate with IL-2 cytokine antibody complex. However, expanding Tregs in the skin did not induce anagen in normal mice, indicating that they are necessary but not sufficient for anagen induction. Also, they fail to suppress autoreactive CD8 T cells in the skin to reverse established AA in C3H\/HeJ mice. These results suggest that Treg expansion alone is not sufficient for AA treatment, and combined immunotherapy is required.<\/jats:p>","DOI":"10.3389\/fimmu.2022.874778","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T12:40:02Z","timestamp":1655815202000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Selective Expansion of Tregs Using the IL-2 Cytokine Antibody Complex Does Not Reverse Established Alopecia Areata in C3H\/HeJ Mice"],"prefix":"10.3389","volume":"13","author":[{"given":"Eunjin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.464","article-title":"Lifetime Incidence Risk of Alopecia Areata Estimated at 2.1% by Rochester Epidemiology Project, 1990-2009","volume":"134","author":"Mirzoyev","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1103442","article-title":"Alopecia Areata","volume":"366","author":"Gilhar","year":"2012","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16808","article-title":"Alopecia Areata: A Review of Disease Pathogenesis","volume":"179","author":"Rajabi","year":"2018","journal-title":"Br J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.23580.x","article-title":"Alopecia Areata Induced in C3H\/HeJ Mice by Interferon-Gamma: Evidence for Loss of Immune Privilege","volume":"124","author":"Gilhar","year":"2005","journal-title":"J Invest Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3645","article-title":"Alopecia Areata is Driven by Cytotoxic T Lymphocytes and is Reversed by JAK Inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.201","article-title":"JAK Inhibition as a Therapeutic Strategy for Immune and Inflammatory Diseases","volume":"16","author":"Schwartz","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1500973","article-title":"Pharmacologic Inhibition of JAK-STAT Signaling Promotes Hair Growth","volume":"1","author":"Harel","year":"2015","journal-title":"Sci Adv"},{"key":"B8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2147\/CCID.S309215","article-title":"A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata","volume":"14","author":"Dillon","year":"2021","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32987-8","article-title":"JAK Inhibitors and Alopecia Areata","volume":"393","author":"Gilhar","year":"2019","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.05.027","article-title":"JAK Inhibitors for Treatment of Alopecia Areata","volume":"138","author":"Wang","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0232-6","article-title":"Treg Cell-Based Therapies: Challenges and Perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13535","article-title":"Regulatory T Cells in Autoimmune Skin Diseases","volume":"28","author":"Ujiie","year":"2019","journal-title":"Exp Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T Cells in Autoimmune Disease","volume":"19","author":"Dominguez-Villar","year":"2018","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nri3823","article-title":"The Promise of Low-Dose Interleukin-2 Therapy for Autoimmune and Inflammatory Diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cell.2017.05.002","article-title":"Regulatory T Cells in Skin Facilitate Epithelial Stem Cell Differentiation","volume":"169","author":"Ali","year":"2017","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.176","article-title":"Transfer of Alopecia Areata to C3H\/HeJ Mice Using Cultured Lymph Node-Derived Cells","volume":"135","author":"Wang","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3685","article-title":"Inhibiting Janus Kinases to Treat Alopecia Areata","volume":"20","author":"Divito","year":"2014","journal-title":"Nat Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2014.30","article-title":"Ex Vivo Expanded Autologous Polyclonal Regulatory T Cells Suppress Inhibitor Formation in Hemophilia","volume":"1","author":"Sarkar","year":"2014","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.11.020","article-title":"Front-Line Memory T Cells Think Outside the T-Box","volume":"43","author":"Snyder","year":"2015","journal-title":"Mostly Immun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.11.008","article-title":"T-Box Transcription Factors Combine With the Cytokines TGF-Beta and IL-15 to Control Tissue-Resident Memory T Cell Fate","volume":"43","author":"Mackay","year":"2015","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.09.007","article-title":"CD4+ T Cell Help Guides Formation of CD103+ Lung-Resident Memory CD8+ T Cells During Influenza Viral Infection","volume":"41","author":"Laidlaw","year":"2014","journal-title":"Immunity"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.08.035","article-title":"Frontiers in Alopecia Areata Pathobiology Research","volume":"144","author":"Gilhar","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082824","article-title":"In Vivo Expansion of T Reg Cells With IL-2-mAb Complexes: Induction of Resistance to EAE and Long-Term Acceptance of Islet Allografts Without Immunosuppression","volume":"206","author":"Webster","year":"2009","journal-title":"J Exp Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0351-z","article-title":"Regulatory T Cell Adaptation in the Intestine and Skin","volume":"20","author":"Whibley","year":"2019","journal-title":"Nat Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01186","article-title":"Mechanisms Underlying the Anti-Inflammatory and Immunosuppressive Activity of Ruxolitinib","volume":"9","author":"Elli","year":"2019","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01745.x","article-title":"Transient CD44 Variant Isoform Expression and Reduction in CD4(+)\/CD25(+) Regulatory T Cells in C3H\/HeJ Mice With Alopecia Areata","volume":"118","author":"Zoller","year":"2002","journal-title":"J Invest Dermatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210308","article-title":"Alopecia Areata Patients Show Deficiency of FOXP3+CD39+ T Regulatory Cells and Clonotypic Restriction of Treg TCRbeta-Chain, Which Highlights the Immunopathological Aspect of the Disease","volume":"14","author":"Hamed","year":"2019","journal-title":"PLos One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2013.01.006","article-title":"Impaired Inhibitory Function of Circulating CD4+CD25+ Regulatory T Cells in Alopecia Areata","volume":"70","author":"Shin","year":"2013","journal-title":"J\u00a0Dermatol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23692.x","article-title":"Transfer of CD8(+) Cells Induces Localized Hair Loss Whereas CD4(+)\/CD25(-) Cells Promote Systemic Alopecia Areata and CD4(+)\/CD25(+) Cells Blockade Disease Onset in the C3H\/HeJ Mouse Model","volume":"124","author":"McElwee","year":"2005","journal-title":"J\u00a0Invest Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd1866","article-title":"Blockade of IL-7 Signaling Suppresses Inflammatory Responses and Reverses Alopecia Areata in C3H\/HeJ Mice","volume":"7","author":"Dai","year":"2021","journal-title":"Sci Adv"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/science.1109745","article-title":"The Structure of Interleukin-2 Complexed With Its Alpha Receptor","volume":"308","author":"Rickert","year":"2005","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.648408","article-title":"Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases","volume":"12","author":"Grasshoff","year":"2021","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.504","article-title":"Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata","volume":"150","author":"Castela","year":"2014","journal-title":"JAMA Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jid.2020.08.015","article-title":"Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing Its Impact on T Regulatory Cell and NK Cell Populations","volume":"141","author":"Le Duff","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1322","article-title":"Selective IL-2 Responsiveness of Regulatory T Cells Through Multiple Intrinsic Mechanisms Supports the Use of Low-Dose IL-2 Therapy in Type 1 Diabetes","volume":"64","author":"Yu","year":"2015","journal-title":"Diabetes"},{"key":"B36","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.130.5.2203","article-title":"The Fate of Interleukin-2 After In Vivo Administration","volume":"130","author":"Donohue","year":"1983","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1126\/science.1122927","article-title":"Selective Stimulation of T Cell Subsets With Antibody-Cytokine Immune Complexes","volume":"311","author":"Boyman","year":"2006","journal-title":"Science"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.04.015","article-title":"Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation Through Distinct Conformational Mechanisms","volume":"42","author":"Spangler","year":"2015","journal-title":"Immunity"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nri3156","article-title":"The Role of Interleukin-2 During Homeostasis and Activation of the Immune System","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1899671","DOI":"10.1080\/2162402X.2021.1899671","article-title":"Crystal Structure of Human Interleukin-2 in Complex With TCB2, A New Antibody-Drug Candidate With Antitumor Activity","volume":"10","author":"Kim","year":"2021","journal-title":"Oncoimmunology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1681869","DOI":"10.1080\/2162402X.2019.1681869","article-title":"TCB2, a New Anti-Human Interleukin-2 Antibody, Facilitates Heterodimeric IL-2 Receptor Signaling and Improves Anti-Tumor Immunity","volume":"9","author":"Lee","year":"2020","journal-title":"Oncoimmunology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2012.01.093","article-title":"Selectively Expanding Subsets of T Cells in Mice by Injection of Interleukin-2\/Antibody Complexes: Implications for Transplantation Tolerance","volume":"44","author":"Boyman","year":"2012","journal-title":"Transplant Proc"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12008","article-title":"Interleukin-2\/Anti-Interleukin-2 Monoclonal Antibody Immune Complex Suppresses Collagen-Induced Arthritis in Mice by Fortifying Interleukin-2\/STAT5 Signalling Pathways","volume":"137","author":"Lee","year":"2012","journal-title":"Immunology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0070-2","article-title":"A Human Anti-IL-2 Antibody That Potentiates Regulatory T Cells by a Structure-Based Mechanism","volume":"24","author":"Trotta","year":"2018","journal-title":"Nat Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aba5264","article-title":"An IL-2 Mutein Engineered to Promote Expansion of Regulatory T Cells Arrests Ongoing Autoimmunity in Mice","volume":"5","author":"Khoryati","year":"2020","journal-title":"Sci Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.874778\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T22:51:01Z","timestamp":1675896661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.874778\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2022.874778"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.874778","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"article-number":"874778"}}